Thanks for he kind words old mate, but I really don't know...

Thanks for he kind words old mate, but I really don't know nothin'. I'm still in cause I reckon that there is a chance that we just might jag something (big). Carter's not a sniper, so for him to focus on one product only, would be a mistake. But shotguns are different and even a mug can hit something. Big dog's recent comments about Carter's enthusiasm for Anagrelide could very well be significant. Plenty of irons in the fire at the moment which means there's some redundancy. I reckon stiffy-mist might fall into that category.

A realistic comparison is ACR which peaked at a MC of over 400 million when Eli Lilly started selling their testosterone product. Problem was they only had one product of substance and I think it's fair to say that the FDA investigation into cardio-respiratory issues associated with testosterone supplements as well as the failure to prevent generics in the market killed that run.

Anyway, all good.